Cite
MLA Citation
U. Jaeger et al.. “P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION.” HemaSphere, vol. 6, n.d., pp. 1433–1434. http://access.bl.uk/ark:/81055/vdc_100159756912.0x00000b